Showing 41-60 of 489 for: Cochrane Systematic Reviews > Gastrointestinal 
- Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding
Cochrane Systematic Reviews, 5-Aug-2009
Endoscopic treatment is recommended for initial hemostasis in non-variceal upper gastrointestinal bleeding. Many endoscopic hemostatic devices are used. Argon Plasma Coagulation (APC) is an alternative.
- Aromatherapy for treatment of postoperative nausea and vomiting
Cochrane Systematic Reviews, 9-Mar-2012
Postoperative nausea and vomiting is a common and unpleasant phenomenon and current therapies are not always effective for all patients. Aromatherapy has been suggested as a possible addition to the available treatment strategies.
- Artificial and bioartificial support systems for liver failure
Cochrane Systematic Reviews, 9-Oct-2008
Artificial and bioartificial liver support systems may 'bridge' patients with acute or acute-on-chronic liver failure to liver transplantation or recovery.
- Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Cochrane Systematic Reviews, 9-Aug-2012
Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine and 6-mercaptopurine for the maintenance of remission is still controversial.
- Azathioprine for primary biliary cirrhosis
Cochrane Systematic Reviews, 15-Oct-2008
Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting.
- Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 18-Apr-2013
The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was performed to assess the effective
- Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 30-Oct-2015
The therapeutic role of azathioprine (AZA) and 6-mercaptopurine (6-MP) remains controversial due to their relatively slow onset of action and potential for adverse events. An updated meta-analysis was performed to evaluate the efficacy of these agents for
- Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults
Cochrane Systematic Reviews, 5-Jul-2012
Non-selective beta-blockers are used as a first-line treatment for primary prevention in patients with medium- to high-risk oesophageal varices. The effect of non-selective beta-blockers on mortality is debated and many patients experience adverse events.
- Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Cochrane Systematic Reviews, 16-Feb-2010
Nonalcoholic fatty liver disease (NAFLD) is increasingly recognised as a condition associated with overweight or obesity that may progress to end-stage liver disease. NAFLD histology resembles alcohol-induced liver injury, but occurs in patients with no h
- Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children
Cochrane Systematic Reviews, 9-Nov-2011
Faecal incontinence is a common and potentially distressing disorder of childhood.
- Benzodiazepine receptor antagonists for hepatic encephalopathy
Cochrane Systematic Reviews, 23-Sep-2008
Hepatic encephalopathy may be associated with accumulation of substances that bind to a receptor-complex in the brain resulting in neural inhibition. Benzodiazepine receptor antagonists may have a beneficial effect on patients with hepatic encephalopathy.
- Bicyclol for chronic hepatitis B
Cochrane Systematic Reviews, 16-Oct-2008
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis B. Until now, systematic reviews of bicyclol therapy have not been performed.
- Bicyclol for chronic hepatitis C
Cochrane Systematic Reviews, 16-Oct-2008
Bicyclol is a novel synthetic 'anti-hepatitis' drug, used in China for chronic hepatitis C. Until now, systematic reviews on bicyclol therapy have not been performed.
- Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
Cochrane Systematic Reviews, 15-Oct-2008
Non-alcoholic fatty liver disease is a condition characterised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake. Some patients develop non-alcoholic steatohepatitis. Bile acids may potentially protect cellular structure
- Bile acids for primary sclerosing cholangitis
Cochrane Systematic Reviews, 6-Dec-2010
Primary sclerosing cholangitis is a progressive chronic cholestatic liver disease that usually leads to the development of cirrhosis. Studies evaluating bile acids in the treatment of primary sclerosing cholangitis have shown a potential benefit of their
- Bile acids for viral hepatitis
Cochrane Systematic Reviews, 16-Oct-2008
Trials have assessed bile acids for patients with viral hepatitis, but no consensus has been reached regarding their usefulness.
- Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults
Cochrane Systematic Reviews, 13-Jun-2012
Faecal incontinence is a particularly embarrassing and distressing condition with significant medical, social and economic implications. Anal sphincter exercises (pelvic floor muscle training) and biofeedback therapy have been used to treat the symptoms o
- Blood transfusion for treating malarial anaemia
Cochrane Systematic Reviews, 2-Aug-2010
Blood transfusion is used in patients with severe malarial anaemia, but risks adverse reactions, transmission of disease, and is complicated to organize in developing countries.
- Branched-chain amino acids for people with hepatic encephalopathy
Cochrane Systematic Reviews, 9-Sep-2015
Hepatic encephalopathy is a brain dysfunction with neurological and psychiatric changes associated with liver insufficiency or portal-systemic shunting. The severity ranges from minor symptoms to coma. A Cochrane systematic review including 11 randomised
- Budesonide for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 29-May-2015
Corticosteroids are commonly used for the induction of remission in Crohn's disease. However, traditional corticosteroids can cause significant adverse events. Budesonide is an alternative glucocorticoid with limited systemic bioavailability.
